Related Experiment Video
Updated: Jul 19, 2026
12:36
Whole Ovary Immunofluorescence, Clearing, and Multiphoton Microscopy for Quantitative 3D Analysis of the Developing Ovarian Reserve in Mouse
Published on: September 3, 2021
[Oocyte quality and ovarian reserve]
1Unités AMP CHU Paris VII et Eylau-La Muette.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|October 24, 2006
Summary
Predicting oocyte quality remains challenging. However, antral follicle count and anti-Müllerian hormone levels are key indicators for ovarian reserve and assisted reproductive technology success in women with uncertain ovarian function.
Area of Science:
- Reproductive Endocrinology
- Infertility Research
- Assisted Reproductive Technology
Background:
- Oocyte quality is crucial for successful conception and assisted reproductive technology (ART).
- Current clinical and biological markers have limitations in accurately predicting oocyte quality.
- Assessing ovarian reserve is vital for managing infertility and optimizing ART outcomes.
Purpose of the Study:
- To evaluate the predictive value of various parameters for oocyte quality.
- To identify reliable markers for ovarian reserve in women with uncertain ovarian function.
- To determine the best indicators for assisted reproductive technology (ART) outcomes.
Main Methods:
- Analysis of clinical and biological parameters in relation to oocyte quality.
- Assessment of antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) levels.
- Correlation of follicle-stimulating hormone (FSH) with estradiol (E2) levels, AFC, and patient age.
Main Results:
- No single clinical or biological parameter reliably predicts oocyte quality.
- Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are significant discriminatory markers for ovarian reserve.
- AFC and AMH correlate with assisted reproductive technology (ART) outcomes.
- FSH levels require correlation with estradiol (E2), AFC, and age for comprehensive assessment.
Conclusions:
- Oocyte quality prediction remains an unmet clinical need.
- AFC and AMH are valuable tools for assessing ovarian reserve and predicting ART success.
- Integrated assessment of hormonal levels, AFC, and age is recommended for reproductive health evaluations.
Related Concept Videos
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:22Oogenesis
Oogenesis, the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
01:20Folliculogenesis
Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...